Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Keppler

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Metal-Based Drugs|January 1, 1995
Synthesis and Characterization of New Ethylenediamine Platinum(IV) Complexes Containing Lipophilic Carboxylate LigandsM Galanski, B K Keppler
Metal-Based Drugs|January 1, 1994
New tumor-inhibiting metal complexes. Chemistry and antitumor propertiesB K Keppler, M Hartmann
Arzneimittel-Forschung|December 1, 1986
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexesB K Keppler, D Schmähl
Arzneimittel-Forschung|January 1, 1985
Antitumor activity of 1.3-diketonato zirconium (IV) and hafnium (IV) complexesB K Keppler, K Michels
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agentsB K Keppler, W Rupp
Inorganic Chemistry|March 13, 1996
Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic PathwayMathea Sophia Galanski, B K Keppler
Metal-Based Drugs|January 1, 1994
Antitumour Organometallics. III. In Vivo Activity of Diphenylantimony(III) and Diorganotin(IV) Dithiophosphorus Derivatives Against P388 LeukemiaB K Keppler, C Silvestru, I Haiduc
Arzneimittel-Forschung|July 1, 1987
Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III). Two representatives of a new class of inorganic antitumor agentsB K Keppler, W Balzer, V Seifried
Arzneimittel-Forschung|January 1, 1985
Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compoundsB K Keppler, A Diez, V Seifried
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresisA Küng, T Pieper, B K Keppler
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Metal-Based Drugs|January 1, 1995
Synthesis and Characterization of New Ethylenediamine Platinum(IV) Complexes Containing Lipophilic Carboxylate LigandsM Galanski, B K Keppler
Metal-Based Drugs|January 1, 1994
New tumor-inhibiting metal complexes. Chemistry and antitumor propertiesB K Keppler, M Hartmann
Arzneimittel-Forschung|December 1, 1986
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexesB K Keppler, D Schmähl
Arzneimittel-Forschung|January 1, 1985
Antitumor activity of 1.3-diketonato zirconium (IV) and hafnium (IV) complexesB K Keppler, K Michels
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agentsB K Keppler, W Rupp
Inorganic Chemistry|March 13, 1996
Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic PathwayMathea Sophia Galanski, B K Keppler
Metal-Based Drugs|January 1, 1994
Antitumour Organometallics. III. In Vivo Activity of Diphenylantimony(III) and Diorganotin(IV) Dithiophosphorus Derivatives Against P388 LeukemiaB K Keppler, C Silvestru, I Haiduc
Arzneimittel-Forschung|July 1, 1987
Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III). Two representatives of a new class of inorganic antitumor agentsB K Keppler, W Balzer, V Seifried
Arzneimittel-Forschung|January 1, 1985
Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compoundsB K Keppler, A Diez, V Seifried
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresisA Küng, T Pieper, B K Keppler
Pageof 7